The Beatson West of Scotland Cancer Centre is a specialised cancer care centre in Glasgow, Scotland. Until recently it had facilities in Gartnavel General Hospital, the Western Infirmary and Glasgow Royal Infirmary.

There are 30 beds in Beatson West of Scotland Cancer Centre.

During the past decade, Beatson West of Scotland Cancer Centre conducted 218 clinical trials. In the 10-year time frame, 218 clinical trials started and 82 clinical trials were completed, i.e. on average, 37.6% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 53 clinical trials were completed. i.e. 67.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beatson West of Scotland Cancer Centre" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 31 trials, followed by "Hoffmann-La Roche" with 26 trials sponsored, "University College, London" with 22 trials sponsored, "Institute of Cancer Research, United Kingdom" with 12 trials sponsored and "Pfizer" with 12 trials sponsored. Other sponsors include 290 different institutions and companies that sponsored additional 160 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beatson West of Scotland Cancer Centre" #1 collaborator was "Cancer Research UK" with 33 trials as a collaborator, "Merck Sharp & Dohme LLC" with 15 trials as a collaborator, "AstraZeneca" with 13 trials as a collaborator, "Pfizer" with 9 trials as a collaborator and "University of Glasgow" with 8 trials as a collaborator. Other collaborators include 268 different institutions and companies that were collaborators in the rest 209 trials.

According to Clinical.Site data, the most researched conditions in "Beatson West of Scotland Cancer Centre" are "Breast Cancer" (32 trials), "Ovarian Cancer" (19 trials), "Prostate Cancer" (14 trials), "Fallopian Tube Cancer" (12 trials) and "Metastatic Breast Cancer" (10 trials). Many other conditions were trialed in "Beatson West of Scotland Cancer Centre" in a lesser frequency.

Most popular intervention types in "Beatson West of Scotland Cancer Centre" are "Drug" (341 trials), "Radiation" (47 trials), "Other" (45 trials), "Biological" (39 trials) and "Procedure" (36 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "radiation therapy" (21 trials), "Paclitaxel" (19 trials), "Atezolizumab" (18 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Beatson West of Scotland Cancer Centre" are 308 trials for "All" genders, 62 trials for "Female" genders and 28 trials for "Male" genders.

Currently, there are 140 active trials in "Beatson West of Scotland Cancer Centre". 1 are not yet recruiting, 70 are recruiting, 67 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 181 completed trials in Beatson West of Scotland Cancer Centre, 1 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Beatson West of Scotland Cancer Centre, 74 "Phase 1" clinical trials were conducted, 181 "Phase 2" clinical trials and 152 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 14 trials that are defined as “Not Applicable".